Seleccione otro país
Bienvenido a Lyxor España
Por favor, lea la información importante aquí incluida antes de continuar a nuestra página web

Información relevante 

Los Lyxor ETFs presentados en la página web de lyxoretf.com, pueden ser objeto de restricciones en lo que respecta a la inversión por determinadas personas o en determinados países, en virtud de las distintas regulaciones nacionales aplicables a dichas personas o en dichos países. Cualquier persona que acceda a esta página web desde una jurisdicción en la cual se aplican dichas restricciones tiene que informarse al respecto y observar dichas restricciones. Por consiguiente, le corresponde a usted asegurarse de que, efectivamente está autorizado a invertir en los Lyxor ETFs presentados en esta página web. Invirtiendo en estos productos, usted garantiza a Société Générale que está efectivamente autorizado a invertir. Inversores españoles se deben dirigir a www.lyxoretf.es

La información contenida en esta página web no constituye una oferta o invitación para adquirir o vender los productos aquí descritos a personas sometidas a  jurisdicciones donde:

(a) dicha oferta o invitación no esté autorizada;
(b) Lyxor Asset Management no esté cualificada para hacer dicha oferta o invitación;
(c)  sea ilícito hacer dicha oferta o invitación.

Los ETFs referidos en esta página web no han estado y no estarán registrados conforme al U.S Securities Act de1933, por lo tanto, no pueden ser ofertados ni vendidos en los EE.UU sin registro previo o solo en caso de excepción de registro conforme al  al Securities Act. Por consiguiente, los ETFs listados en esta página web no pueden ser vendidos a “U.S persons”, ni transferidos a los Estados Unidos a menos que dicha transacción esté sujeta a los requisitos de registro conforme a la ley Americana.

Esta página web es de carácter comercial y no de carácter legal. No se garantiza la exactitud, exhaustividad o pertinencia de la información aunque ha sido establecida a partir de fuentes consideradas como fiables.
La información presentada en esta página web se basa en información de mercado constada en un momento dado que puede variar con posterioridad a su publicación. El valor de reembolso de los Lyxor ETFs puede ser inferior al montante de la inversión inicial. En el peor de los casos, los inversores podrían perder hasta la totalidad de su inversión, por lo que se recomienda a los inversores consultar la sección« factores de riesgo » del folleto del producto. El precio de algunos Lyxor ETFs puede ser sensible a riesgos de tipo de cambio entre la cotización del ETF y/o la divisa del índice y/o la divisa del componente del índice.

Todos los LyxorETFs presentados en esta página web han sido aprobados por la “Autorité des Marchés Financiers (AMF)” y son objeto de un folleto aprobado por la AMF y pasaporteado en la CNMV conforme a la Directiva 2003/71/CE. Dichos folletos están disponibles en esta página Web.

La documentación relativa a los Lyxor ETFs preverá métodos de ajuste y de sustitución para tener en cuenta que consecuencias tendría cualquier suceso extraordinario que afecte a uno o varios de los subyacentes de estos productos.

Antes de invertir en un Lyxor ETF, usted debe hacer su propia valoración del riesgo desde un punto de vista legal, fiscal y  contable, sin depender exclusivamente de la información que le proporcionamos y consultando, si lo estima necesario, sus propios asesores en la materia o cualquier otro asesor independiente.

El inversor de ETFs estará expuesto a los siguientes factores de riesgo: Riesgo de pérdida del capital invertido, al no existir ninguna garantía, como consecuencia de un movimiento desfavorable del Índice de Referencia, Riesgo de que el objetivo de gestión solo se cumpla parcialmente, Riesgo de contrapartida como resultado de la utilización de los instrumentos financieros (OTC) formalizados con un establecimiento de crédito. Se recomienda a los inversores que consulten la sección del folleto antes de invertir.

En la medida en que cumpla con la legislación aplicable, ninguna entidad del Grupo Société Générale acepta responsabilidad alguna por las consecuencias financieras o de cualquier otra naturaleza que resulten de la inversión en este producto.

Utilizamos las Cookies para asegurar el correcto funcionamiento de nuestro sitio web, y para recopilar datos estadísticos sobre usuarios de modo que podamos mejorar el sitio web. Si continúa navegando por este sitio web usted aceptará nuestro uso de las Cookies.Para más información o para modificar sus preferencias sobre CookiesHaga click aquí

How central bank exit strategies could affect your portfolio 



The Fed at the forefront

After a decade of unprecedentedly loose monetary policy, the Fed hiked rates three times in 2017 and, by the end of the year, had also begun reducing the size of its balance sheet. It was able to do so because of the strong growth of the US economy. Though there is no guarantee growth will continue, this strength shows no sign of waning just yet so we expect further rate hikes this year, starting in March. The only question is how many, with three currently looking likeliest in our view. Higher growth could force the Fed to act faster.


Next in line: the ECB

Other major central banks look likely to follow in the Fed’s footsteps, and first in line is the ECB. For the moment it’s still adding to its balance sheet by buying assets as part of its quantitative easing programme, although it’s doing so more slowly: it has reduced its monthly purchases from EUR 60 billion to EUR 30 billion. What’s more, it has stated it will conclude these purchases by the end of September.

When it comes to tightening policy, the ECB remains well behind the Fed, with its key policy rate still at 0%. It’s said it will only start raising rates well after the conclusion of its asset purchases, which means hikes are unlikely before 2019 in our opinion. Should growth surprise to the upside, don’t rule out a late 2018 hike.  


Next in line: the ECB

Source: Lyxor Cross Asset  Research January 2018 


Tightening further over the horizon in Japan

After the ECB, the Bank of Japan is likely to be next. It hasn’t really discussed reducing its asset purchases in earnest yet, but it does seem to have been testing the water in recent weeks by referring to a form of tapering. We believe this remains some way off however:  formal announcements are unlikely until the second half of this year, with actual implementation taking place in 2019.


The BoE strikes out on its own (for now)

The Bank of England is something of an outlier as it battles the uncertainties of Brexit.  Much depends on the UK’s progress towards a good trade deal with the EU: should this materialise, it would open the door to rate hikes further down the line.


A mixed picture in emerging markets

What about monetary policy in the emerging world? There’s a difference between those economies compelled to follow Fed policy – Korea has recently hiked rates, for example – and those like China, which have a greater degree of independence.

Inflation is fairly moderate in China so its central bank hasn’t felt the need to hike rates at the same pace as the Fed and is currently adopting a neutral stance. Inflation is higher in countries like Turkey and South Africa so they could see hikes over the coming months. Look out for India, where the central bank is turning more hawkish. Elsewhere, the Brazilian and Russian central banks remain in a very accommodative mood.


The implications for investors

Should investors be worried about the end of ultra-loose monetary policy? We’re concerned about its implications for fixed income, but more sanguine about the outlook for equities.


Bearish on bonds...

We’re increasingly cautious on fixed income and believe protection may be harder to find among traditional strategies. As policy rates rise, bond yields are likely to move higher at the short-end of the curve. What’s more, with the Fed already selling assets we suspect there are even implications for longer-dated issues such as the ten-year Treasuries, albeit they still something of a safe haven.

Having favoured an underweight US Treasury position for some months, we feel the time has now come to adopt similar stances in eurozone fixed income and Japanese government bonds. We’re also cautious about corporate bonds – and US high yield in particular – as well as emerging market sovereigns denominated in US dollars. With the Fed hiking rates, these risky assets will lose some of their allure relative to risk-free assets such as US Treasuries.

It could be time to consider using less conventional strategies like inflation breakevens and floaters, which are capable of offering some protection against rising rates and inflation.The so-called “base effect” in oil prices will be even stronger in the coming months provided that oil prices stay at current levels, which seems likely due to solid macro conditions globally. Those conditions, allied to the moderate wage pressures observed in developed countries, led us to upgrade USD breakevens to overweight recently. 


...but optimistic about equities

Tighter policy is also a headwind for the equity markets, but there are strong forces at play which make us more optimistic about the prospects for stocks:  

Accommodation will only be reversed very gradually – in stark contrast to the aggressive way in which it was implemented a decade ago. That should soothe any troubled minds among investors. 

The global economy shoul continue to strengthen – the eurozone is enjoying its strongest expansion for a decade, the US economy is performing well, Japan is recovering and it’s clear emerging markets – especially China – are doing better than had been feared just a few months ago. Stronger economies should mean stronger earnings growth and buoyant equity markets.

This all leads us to prefer equities to fixed income. Within the equity markets, we favour mainland Europe and Japan, whose economies have outperformed expectations and where stocks appear good value. We’re neutral on US equities as we want to be exposed to the strong momentum of the economy and the stock market but valuations aren’t looking as attractive as elsewhere.   


Selective in emerging markets

Monetary tightening in certain emerging economies is likely to represent a headwind to risky assets from those countries, but China’s seemingly sustainable growth should, inour view provide support to emerging market risk assets overall. At the country level we’re overweight Brazil and Russia and neutral in India and China.

Other things on your horizon? Watch our videos on the themes likeliest to move markets in 2018: 

Capex and tax reform

Dig deeper for opportunities in Europe

Asia: this year’s equity hotspot?

Safe haven bonds may be harder to find

All data & opinions are from Lyxor Cross Asset Research team, as at 25 January 2018. Past performance is no guide to future returns

 

THIS COMMUNICATION IS FOR ELIGIBLE COUNTERPARTIES OR PROFESSIONAL CLIENTS ONLY

Fund and charge data: Lyxor ETF, correct as at 25 Januray 2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on www.lyxoretf.com, and upon request to client-services-etf@lyxor.com.

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website www.lyxoretf.com/compliance.

CONFLICTS OF INTEREST This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin